Inflation in the number of eligibility criteria for industry-sponsored phase II cancer clinical trial: illustration over a 20-year period

Contemp Clin Trials. 2012 May;33(3):459. doi: 10.1016/j.cct.2012.02.009. Epub 2012 Feb 16.
No abstract available

Publication types

  • Letter

MeSH terms

  • Clinical Trials, Phase II as Topic / methods*
  • Drug Design*
  • Humans
  • Patient Selection*
  • Time Factors